Cellid, Co., Ltd. (299660.KQ)

KRW 3630.0

(-2.42%)

Inventory Summary of Cellid, Co., Ltd.

Cellid, Co., Ltd.'s latest annual inventory in 2023 was - KRW , up 100.0% from previous year.
Cellid, Co., Ltd.'s latest quarterly inventory in 2024 Q2 was 179.96 Million KRW , up 40.47% from previous quarter.
Cellid, Co., Ltd. reported annual inventory of -10.39 Billion KRW in 2022, down 0.0% from previous year.
Cellid, Co., Ltd. reported annual inventory of - KRW in 2021, down 0.0% from previous year.
Cellid, Co., Ltd. reported quarterly inventory of 179.96 Million KRW for 2024 Q2, up 40.47% from previous quarter.
Cellid, Co., Ltd. reported quarterly inventory of - KRW for 2023 Q2, down 0.0% from previous quarter.

Annual Inventory Chart of Cellid, Co., Ltd. (2023 - 2015)

Historical Annual Inventory of Cellid, Co., Ltd. (2023 - 2015)

Year	Inventory	Inventory Growth
2023	- KRW	100.0%
2022	-10.39 Billion KRW	0.0%
2021	- KRW	0.0%
2020	- KRW	0.0%
2019	- KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q1	128.12 Million KRW	0.0%
2024 Q2	179.96 Million KRW	40.47%
2023 Q2	- KRW	0.0%
2023 Q1	- KRW	100.0%
2023 Q4	- KRW	0.0%
2023 Q3	- KRW	0.0%
2023 FY	- KRW	100.0%
2022 Q4	-10.39 Billion KRW	10.89%
2022 Q2	- KRW	0.0%
2022 FY	-10.39 Billion KRW	0.0%
2022 Q1	- KRW	0.0%
2022 Q3	-11.66 Billion KRW	0.0%
2021 Q2	- KRW	0.0%
2021 FY	- KRW	0.0%
2021 Q3	-11.96 Billion KRW	0.0%
2021 Q4	- KRW	100.0%
2021 Q1	- KRW	0.0%
2020 Q1	- KRW	0.0%
2020 Q2	- KRW	0.0%
2020 FY	- KRW	0.0%
2020 Q3	- KRW	0.0%
2020 Q4	- KRW	0.0%
2019 FY	- KRW	0.0%
2019 Q3	- KRW	0.0%
2019 Q1	- KRW	0.0%
2019 Q4	- KRW	0.0%
2019 Q2	- KRW	0.0%
2018 Q1	- KRW	0.0%
2018 FY	- KRW	0.0%
2018 Q2	- KRW	0.0%
2018 Q4	- KRW	0.0%
2017 FY	- KRW	0.0%
2017 Q1	- KRW	0.0%
2017 Q4	- KRW	0.0%
2016 FY	- KRW	0.0%
2015 FY	- KRW	0.0%

Peer Inventory Comparison of Cellid, Co., Ltd.

Name	Inventory	Inventory Difference
Sam Chun Dang Pharm. Co., Ltd	35.26 Billion KRW	100.0%
Hyundai Bioscience Co., Ltd.	2.58 Billion KRW	100.0%
ST Pharm Co.,Ltd.	120.73 Billion KRW	100.0%
ABL Bio Inc.	- KRW	NaN%